mathec  
 
Offres d’emploi et de stages
Espace membre
 
 
 

 

     
  ACTUALITES
 
  BIBLIOGRAPHIE
   
 
 
   
 
  • • 13 Octobre 2017

    Les 3èmes rencontres Sanofi autour de l’Autogreffe
    Paris, France


    • 20 au 21 octobre 2017

    Journée scientifique du GFRS,
    Marseille, France


    • 17 novembre 2017

    4ème journée de la SSc des CRMR Maladies Auto-Immunes Systémiques Rares,
    Université Paris Descarte, Paris, France


    • 15 au 17 février 2018

    5th Systemic sclerosis world congress,
    Bordeaux, France


    • 18 au 31 mars 2018

    44th Annual meeting of the EBMT,
    Lisbonne, Portugal

   
  AGENDA
 
 
 
BIBLIOGRAPHIES MATHEC   ACTUALITES BIBLIOGRAPHIQUES
   
  2017
   
 
ο Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.
Lindsay JO, Allez M, Clark M, Labopin M, Ricart E, Rogler G, Rovira M, Satsangi J, Farge D, Hawkey CJ; ASTIC trial group; European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party; European Crohn's and Colitis Organisation.
Lancet Gastroenterol Hepatol. 2017 Jun;2(6):399-406.
   
 
ο Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.
Farge D, Burt RK, Oliveira MC, Mousseaux E, Rovira M, Marjanovic Z, de Vries-Bouwstra J, Del Papa N, Saccardi R, Shah SJ, Lee DC, Denton C, Alexander T, Kiely DG, Snowden JA; EBMT ADWP Scleroderma Working Group.
Bone Marrow Transplant. 2017 May 22. doi: 10.1038/bmt.2017.56..
   
 
ο Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell Transplantation.
Racke MK, Imitola J.
JAMA Neurol. 2017 Apr 1;74(4):392-394. doi: 10.1001/jamaneurol.2016.5925.
   
 
ο Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Paolo A. Muraro, MD; Marcelo Pasquini, MD; Harold L. Atkins, MD; James D. Bowen, MD; Dominique Farge, MD; Athanasios Fassas, MD; Mark S. Freedman, MD; George E. Georges, MD; Francesca Gualandi, MD; Nelson Hamerschlak, MD; Eva Havrdova, MD; Vassilios K. Kimiskidis, MD; Tomas Kozak, MD; Giovanni L. Mancardi, MD; Luca Massacesi, MD; Daniela A. Moraes, MD; Richard A. Nash, MD; Steven Pavletic, MD; Jian Ouyang, MD; Montserrat Rovira, MD; Albert Saiz, MD; Belinda Simoes, MD; Marek Trneny, MD; Lin Zhu, MD; Manuela Badoglio, MSc; Xiaobo Zhong, MS; Maria Pia Sormani, PhD; Riccardo Saccardi, MD; for the Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group
JAMA Neurol. Published online February 20, 2017. doi:10.1001/jamaneurol.2016.5867.
   
 
ο Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.
Farge D, Arruda LC, Brigant F, Clave E, Douay C, Marjanovic Z, Deligny C, Maki G, Gluckman E, Toubert A, Moins-Teisserenc H.
J Hematol Oncol. 2017 Jan 19;10(1):21. doi: 10.1186/s13045-016-0388-5.
   
  2016
   
 
ο Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus. 1 (THEX1) Autoantibodies in Scleroderma and Lupus
Azzouz DF, Martin GV, Arnoux F, Balandraud N, Martin T, Dubucquoi S, Hachulla E, Farge-Bancel D, Tiev K, Cabane J, Bardin N, Chiche L, Martin M, Caillet EC, Kanaan SB, Harlé JR, Granel B, Diot E, Roudier J, Auger I, Lambert NC.
PLoS One. 2016 Sep 12;11(9):e0160283. doi: 10.1371/journal.pone.0160283.
   
 
ο Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients.
Michel L, Farge D, Baraut J, Marjanovic Z, Jean-Louis F, Porcher R, Grigore EI, Deligny C, Romijn F, Arruda LC, van Pelt J, Levarht N, Verrecchia F, van Laar JM.
Bone Marrow Transplant. 2016 Aug;51(8):1146-9. doi: 10.1038/bmt.2016.77.
   
 
ο Can positron emission tomography be useful to manage systemic sclerosis cardiac involvement?.
Redureau E, Lairez O, Hitzel A, Pugnet G..
J Nucl Cardiol. 2016 Aug 26.
   
 
ο Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?.
Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A, Kyrcz-Krzemien S, Daikeler T, Alexander T, Finke J, Badoglio M, Simões B, Snowden JA, Farge D.
Bone Marrow Transplant. 2016 Jun.
   
 
ο Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study..
Hachulla E, Hatron PY, Carpentier P, Agard C, Chatelus E, Jego P, Mouthon L, Queyrel V, Fauchais AL, Michon-Pasturel U, Jaussaud R, Mathian A, Granel B, Diot E, Farge-Bancel D, Mekinian A, Avouac J, Desmurs-Clavel H, Clerson P; SEDUCE study group.
Ann Rheum Dis. 2016 Jun;75(6):1009-15. doi: 10.1136/annrheumdis-2014-207001.
   
 
ο Hematopoietic stem cell transplantation in Europe 2014: more than 40?000 transplants annually..
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M.
Bone Marrow Transplant. 2016 Jun;51(6):786-92. doi: 10.1038/bmt.2016.20.
   
 
ο Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network..
Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, Bienvenu B, Abad S, Rigolet A, Deroux A, Sene D, Perlat A, Marie I, Feurer E, Hachulla E, Fain O, Clavel G, Riviere S, Bouche PA, Gueudry J, Pugnet G, Le Hoang P, Resche Rigon M, Cacoub P, Bodaghi B, Saadoun D; French Uveitis Network.
Arthritis Rheumatol. 2016 Jun;68(6):1522-30. doi: 10.1002/art.39667.
   
 
ο Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life..
Pugnet G, Pagnoux C, Terrier B, Perrodeau E, Puéchal X, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quemeneur T, Blanchard-Delaunay C, Godmer P, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.
Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S54-9.
   
 
ο Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion..
Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z; le groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.
Rev Med Interne. 2016 May;37(5):307-20. doi: 10.1016/j.revmed.2016.01.005.
   
 
ο Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases..
Arruda LC, Clave E, Moins-Teisserenc H, Douay C, Farge D, Toubert A.
Curr Res Transl Med. 2016 Apr-Jun;64(2):107-13. doi: 10.1016/j.retram.2016.03.004.
   
 
ο Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice..
Kelsey PJ, Oliveira MC, Badoglio M, Sharrack B, Farge D, Snowden JA.
Curr Res Transl Med. 2016 Apr-Jun;64(2):71-82. doi: 10.1016/j.retram.2016.03.003.
   
 
ο Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database..
Saliba L, Moulis G, Abou Taam M, Rousseau V, Chebane L, Petitpain N, Baldin B, Pugnet G, Montastruc JL, Bagheri H.
Fundam Clin Pharmacol. 2016 Apr;30(2):162-71. doi: 10.1111/fcp.12171.
   
 
ο Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide..
Audemard-Verger A, Martin Silva N, Verstuyft C, Costedoat-Chalumeau N, Hummel A, Le Guern V, Sacré K, Meyer O, Daugas E, Goujard C, Sultan A, Lobbedez T, Galicier L, Pourrat J, Le Hello C, Godin M, Morello R, Lambert M, Hachulla E, Vanhille P, Queffeulou G, Potier J, Dion JJ, Bataille P, Chauveau D, Moulis G, Farge-Bancel D, Duhaut P, Saint-Marcoux B, Deroux A, Manuzak J, Francès C, Aumaitre O, Bezanahary H, Becquemont L, Bienvenu B.
PLoS One. 2016 Mar 22;11(3):e0151696. doi: 10.1371/journal.pone.0151696.
   
 
ο Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease
Danion F, Rosine N, Belkhir R, Gottenberg JE, Hachulla E, Chatelus E, Pugnet G, Pers YM, Mariette X, Sibilia J, Seror R; Club Rhumatismes et Inflammation section of the French Society of Rheumatology.
Lupus. 2016 Mar 24. pii: 0961203316640911.
   
  2015
   
 
ο Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial..
Hawkey CJ1, Allez M2, Clark MM1, Labopin M3, Lindsay JO4, Ricart E5, Rogler G6, Rovira M7, Satsangi J8, Danese S9, Russell N10, Gribben J11, Johnson P12, Larghero J13, Thieblemont C14, Ardizzone S15, Dierickx D16, Ibatici A17, Littlewood T18, Onida F19, Schanz U20, Vermeire S21, Colombel JF22, Jouet JP23, Clark E24, Saccardi R25, Tyndall A26, Travis S27, Farge D28.
JAMA. 2015 Dec 15;314(23):2524-34. doi: 10.1001/jama.2015.16700.
   
 
ο Update on mesenchymal stem cell-based therapy in lupus and scleroderma.
Cras A, Farge D, Carmoi T, Lataillade JJ, Wang DD, Sun L.
Arthritis Res Ther. 2015 Nov 3;17:301. doi: 10.1186/s13075-015-0819-7.
   
 
ο Overexpression of Fkbp11, a feature of lupus B cells, leads to B cell tolerance breakdown and initiates plasma cell differentiation..
Ruer-Laventie J, Simoni L, Schickel JN, Soley A, Duval M, Knapp AM, Marcellin L, Lamon D, Korganow AS, Martin T, Pasquali JL, Soulas-Sprauel P.
Immun Inflamm Dis. 2015 Sep;3(3):265-79. doi: 10.1002/iid3.65.
   
 
ο Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015..
Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Marsh JC, Nagler A, Peters C, Velardi A, Mohty M, Madrigal A.
Bone Marrow Transplant. 2015 Aug;50(8):1037-56. doi: 10.1038/bmt.2015.6.
   
 
ο Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion..
Arnaud L, Mathian A, Adoue D, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Papo T, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Schmidt J, Sibilia J, Viallard JF, Viau Brabant A, Wahl D, Bruckert E, Amoura Z; groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.
Rev Med Interne. 2015 Jun;36(6):372-80. doi: 10.1016/j.revmed.2014.10.009.
   
 
ο Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants..
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M; European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2015 Apr;50(4):476-82. doi: 10.1038/bmt.2014.312.
   
 
ο Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial..
Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E, Donelli A, Lugaresi A, Di Bartolomeo P, Rottoli MR, Rambaldi A, Amato MP, Massacesi L, Di Gioia M, Vuolo L, Currò D, Roccatagliata L, Filippi M, Aguglia U, Iacopino P, Farge D, Saccardi R; ASTIMS Haemato-Neurological Collaborative Group, On behalf of the Autoimmune Disease Working Party (ADWP) of the European Group for Blood and Marrow Transplantation (EBMT); ASTIMS Haemato-Neurological Collaborative Group On behalf of the Autoimmune Disease Working Party ADWP of the European Group for Blood and Marrow Transplantation EBMT.
Neurology. 2015 Mar 10;84(10):981-8. doi: 10.1212/WNL.0000000000001329.
   
 
ο Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)..
Snarski E, Snowden JA, Oliveira MC, Simoes B, Badoglio M, Carlson K, Burman J, Moore J, Rovira M, Clark RE, Saiz A, Hadj-Khelifa S, Tan J, Crescimanno A, Musso M, Martin T, Farge D.
Bone Marrow Transplant. 2015 Feb;50(2):216-20. doi: 10.1038/bmt.2014.248.
   
 
ο SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking..
Alexander T, Bondanza A, Muraro PA, Greco R, Saccardi R, Daikeler T, Kazmi M, Hawkey C, Simoes BP, Leblanc K, Fibbe WE, Moore J, Snarski E, Martin T, Hiepe F, Velardi A, Toubert A, Snowden JA, Farge D
Bone Marrow Transplant. 2015 Feb;50(2):173-80. doi: 10.1038/bmt.2014.251.
   
 
ο Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party..
Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D.
Mult Scler. 2015 Feb;21(2):189-97. doi: 10.1177/1352458514541978.
   
  2014
   
 
ο Cardiac assessment before stem cell transplantation for systemic sclerosis--reply..
van Laar JM, Farge D, Tyndall A.
JAMA. 2014 Nov 5;312(17):1803-4. doi: 10.1001/jama.2014.12572.
   
 
ο Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC..
Farge D, Terriou L, Badoglio M, Cras A, Desreumaux P, Hadj-Khelifa S, Marjanovic Z, Moisan A, Dulery R, Faucher C, Hij A, Martin T, Vermersch P, Yakoub-Agha I; SFGM-TC.
Pathol Biol (Paris). 2014 Aug;62(4):204-8. doi: 10.1016/j.patbio.2014.05.012.
   
 
ο Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation..
Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A; European Society for Blood and Marrow Transplantation EBMT.
Bone Marrow Transplant. 2014 Jun;49(6):744-50. doi: 10.1038/bmt.2014.55.
   
 
ο Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial..
van Laar JM and Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kötter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quéré I, Rich É, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socié G, Gratwohl A, Tyndall A; EBMT/EULAR Scleroderma Study Group.
JAMA. 2014 Jun 25;311(24):2490-8. doi: 10.1001/jama.2014.6368.
   
 
ο Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients..
Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L; French Vasculitis Study Group.
J Autoimmun. 2014 May;50:135-41. doi: 10.1016/j.jaut.2014.03.002.
   
 
ο Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study..
Baraut J, Grigore EI, Jean-Louis F, Khelifa SH, Durand C, Verrecchia F, Farge D, Michel L.
Bone Marrow Transplant. 2014 Mar;49(3):349-54. doi: 10.1038/bmt.2013.202.
   
 
ο Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients..
Charles P1, Néel A, Tieulié N, Hot A, Pugnet G, Decaux O, Marie I, Khellaf M, Kahn JE, Karras A, Ziza JM, Deligny C, Tchérakian C, Guillevin L; French Vasculitis Study Group.
Rheumatology (Oxford). 2014 Mar;53(3):532-9. doi: 10.1093/rheumatology/ket381.
   
  2013
   
 
ο Biologics in relapsing polychondritis: a case series..
Moulis G, Sailler L, Pugnet G, Astudillo L, Arlet P.
Clin Exp Rheumatol. 2013 Nov-Dec;31(6):937-9.
   
 
ο Abatacept in relapsing polychondritis..
Moulis G, Pugnet G, Sailler L, Astudillo L, Arlet P.
Ann Rheum Dis. 2013 Nov;72(11):e27. doi: 10.1136/annrheumdis-2013-204336.
   
 
ο Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides..
Charles P, Bienvenu B, Bonnotte B, Gobert P, Godmer P, Hachulla É, Hamidou M, Harlé JR, Karras A, Lega JC, Le Quellec A, Mahr AD, Mouthon L, Papo T, Puéchal X, Pugnet G, Samson M, Sibilia J, Terrier B, Vandergheynst F, Guillevin L; French Vasculitis Study Group.
Presse Med. 2013 Oct;42(10):1317-30. doi: 10.1016/j.lpm.2013.08.003.
   
 
ο Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome..
Blanc F, Longato N, Jung B, Kleitz C, Di Bitonto L, Cretin B, Collongues N, Sordet C, Fleury M, Poindron V, Gottenberg JE, Anne O, Lipsker D, Martin T, Sibilia J, de Seze J.
ISRN Neurol. 2013 Sep 19;2013:501327. doi: 10.1155/2013/501327.
   
 
ο Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort study..
Jamilloux Y, Liozon E, Pugnet G, Nadalon S, Heang Ly K, Dumonteil S, Gondran G, Fauchais AL, Vidal E.
PLoS One. 2013 Jul 24;8(7):e68713. doi: 10.1371/journal.pone.0068713.
   
 
ο Autologous HSCT for systemic sclerosis - Authors' reply..
Burt RK, Shah SJ, Schroeder J, Oliveira MC, Moraes DA, Simoes B, Marjanovic Z, Farge D.
Lancet. 2013 Jun 15;381(9883):2080-1. doi: 10.1016/S0140-6736(13)61241-6.
   
 
ο Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application..
Ménard C, Tarte K.
Stem Cell Res Ther. 2013 Jun 6;4(3):64
   
 
ο Progranulin antibodies in autoimmune diseases..
Thurner L, Preuss KD, Fadle N, Regitz E, Klemm P, Zaks M, Kemele M, Hasenfus A, Csernok E, Gross WL, Pasquali JL, Martin T, Bohle RM, Pfreundschuh M.
J Autoimmun. 2013 May;42:29-38. doi: 10.1016/j.jaut.2012.10.003.
   
 
ο Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children..
Rabusin M, Snowden JA, Veys P, Quartier P, Dalle JH, Dhooge C, Di Bartolomeo P, Gonzalez-Vicent M, Gibson B, Iriondo A, Juergens H, Lisukov I, Messina C, Mialou V, Steward CG, Urban C, Renard M, Giurici N, Peters C, Badoglio M, Ronfani L, Dini G, Farge D, Saccardi R; European Group for Blood and Marrow Transplantation Autoimmune Diseases and Paediatric Disease Working Parties.
Biol Blood Marrow Transplant. 2013 Apr;19(4):666-9. doi: 10.1016/j.bbmt.2012.12.008.
   
 
ο Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry..
Guillevin L, Hunsche E, Denton CP, Krieg T, Schwierin B, Rosenberg D, Matucci-Cerinic M; DUO Registry Group.
Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):71-80.
   
 
ο Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis..
Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes B, Gheorghiade M, Schroeder J, Ruderman E, Farge D, Chai ZJ, Marjanovic Z, Jain S, Morgan A, Milanetti F, Han X, Jovanovic B, Helenowski IB, Voltarelli J.
Lancet. 2013 Mar 30;381(9872):1116-24. doi: 10.1016/S0140-6736(12)62114-X.
   
 
ο Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry..
Alchi B, Jayne D, Labopin M, Demin A, Sergeevicheva V, Alexander T, Gualandi F, Gruhn B, Ouyang J, Rzepecki P, Held G, Sampol A, Voswinkel J, Ljungman P, Fassas A, Badoglio M, Saccardi R, Farge D; EBMT Autoimmune Disease Working Party members.
Lupus. 2013 Mar;22(3):245-53. doi: 10.1177/0961203312470729.
   
 
ο New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation..
Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, Carlson K, Cornillon J, Diez-Martin JL, Gandemer V, Faraci M, Lindemans C, O'Meara A, Mialou V, Renard M, Sedlacek P, Sirvent A, Socié G, Sora F, Varotto S, Sanz J, Voswinkel J, Vora A, Yesilipek MA, Herr AL, Gluckman E, Farge D, Rocha V.
Blood. 2013 Feb 7;121(6):1059-64. doi: 10.1182/blood-2012-07-445965.
   
 
ο Expression of transforming growth factor ß receptor II in mesenchymal stem cells from systemic sclerosis patients..
Vanneaux V, Farge-Bancel D, Lecourt S, Baraut J, Cras A, Jean-Louis F, Brun C, Verrecchia F, Larghero J, Michel L.
BMJ Open. 2013 Jan 7;3(1). pii: e001890. doi: 10.1136/bmjopen-2012-001890.
   
  2012
   
 
ο The EBMT activity survey: 1990-2010..
Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A; European Group for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2012 Jul;47(7):906-23. doi: 10.1038/bmt.2012.66.
   
 
ο Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation..
Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D; EBMT Autoimmune Disease Working Party (ADWP); Paediatric Diseases Working Party (PDWP).
Bone Marrow Transplant. 2012 Jun;47(6):770-90. doi: 10.1038/bmt.2011.185.
   
 
ο Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009..
Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, Clark RE, Kazmi M, Abinun M, Jackson GH, Mackinnon S, Russell NH, Cook G; BSBMT Clinical Trials Committee.
Br J Haematol. 2012 Jun;157(6):742-6. doi: 10.1111/j.1365-2141.2012.09122.x.
   
 
ο A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper..
Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, Kraft G, Mancardi GL, Nash R, Pasquini M, Martin R, Muraro PA; European Blood and Marrow Transplantation Group; Center for International Blood and Marrow Research; HSCT in MS International Study Group.
Mult Scler. 2012 Jun;18(6):825-34. doi: 10.1177/1352458512438454.
   
 
ο Cytokines in systemic sclerosis..
Baraut J, Farge D, Jean-Louis F, Kesmandt H, Durant C, Verrecchia F, Michel L.
Pathol Biol (Paris). 2012 Apr;60(2):127-39. doi: 10.1016/j.patbio.2009.11.003.
   
 
ο Control of B cells expressing naturally occurring autoantibodies..
Pasquali JL, Martin T.
Adv Exp Med Biol. 2012;750:145-56. doi: 10.1007/978-1-4614-3461-0_11.
   
  2011
   
 
ο Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus..
Illei GG, Cervera R, Burt RK, Doria A, Hiepe F, Jayne D, Pavletic S, Martin T, Marmont A, Saccardi R, Voskuyl AE, Farge D.
Ann Rheum Dis. 2011 Dec;70(12):2071-4. doi: 10.1136/ard.2010.148049.
   
 
ο Giant cell arteritis as a cause of acute myocarditis in the elderly..
Pugnet G, Pathak A, Dumonteil N, Sailler L.
J Rheumatol. 2011 Nov;38(11):2497. doi: 10.3899/jrheum.110609.
   
 
ο Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres..
Fransen J, Popa-Diaconu D, Hesselstrand R, Carreira P, Valentini G, Beretta L, Airo P, Inanc M, Ullman S, Balbir-Gurman A, Sierakowski S, Allanore Y, Czirjak L, Riccieri V, Giacomelli R, Gabrielli A, Riemekasten G, Matucci-Cerinic M, Farge D, Hunzelmann N, Van den Hoogen FH, Vonk MC.
Ann Rheum Dis. 2011 Oct;70(10):1788-92. doi: 10.1136/ard.2010.144360.
   
 
ο Autologous HSCT in systemic sclerosis: a step forward..
Farge D, Gluckman E.
Lancet. 2011 Aug 6;378(9790):460-2. doi: 10.1016/S0140-6736(11)61100-8.
   
 
ο Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party..
Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I, Gualandi F, Fassas A, Martin T, Schwarze CP, Wulffraat N, Buch M, Sampol A, Carreras E, Dubois B, Gruhn B, Güngör T, Pohlreich D, Schuerwegh A, Snarski E, Snowden J, Veys P, Fasth A, Lenhoff S, Messina C, Voswinkel J, Badoglio M, Henes J, Launay D, Tyndall A, Gluckman E, Farge D; EBMT Autoimmune Disease Working Party.
Blood. 2011 Aug 11;118(6):1693-8. doi: 10.1182/blood-2011-02-336156.
   
 
ο Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial..
Burt RK1, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J, Craig R, Hirano I, Marshall K, Ruderman E, Jovanovic B, Milanetti F, Jain S, Boyce K, Morgan A, Carr J, Barr W.
Lancet. 2011 Aug 6;378(9790):498-506. doi: 10.1016/S0140-6736(11)60982-3.
   
  2010
   
 
ο Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies..
Pasquini MC, Griffith LM, Arnold DL, Atkins HL, Bowen JD, Chen JT, Freedman MS, Kraft GH, Mancardi GL, Martin R, Muraro PA, Nash RA, Racke MK, Storek J, Saccardi R.
Biol Blood Marrow Transplant. 2010 Aug;16(8):1076-83. doi: 10.1016/j.bbmt.2010.03.012.
   
 
ο Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis..
Baraut J, Michel L, Verrecchia F, Farge D.
Autoimmun Rev. 2010 Dec;10(2):65-73. doi: 10.1016/j.autrev.2010.08.003.
   
 
ο Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies..
Avouac J, Airò P, Meune C, Beretta L, Dieude P, Caramaschi P, Tiev K, Cappelli S, Diot E, Vacca A, Cracowski JL, Sibilia J, Kahan A, Matucci-Cerinic M, Allanore Y.
J Rheumatol. 2010 Nov;37(11):2290-8. doi: 10.3899/jrheum.100245.
   
 
ο Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database..
Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA.
Ann Rheum Dis. 2010 Oct;69(10):1809-15. doi: 10.1136/ard.2009.114264.
   
 
ο Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis..
Tappenden P, Saccardi R, Confavreux C, Sharrack B, Muraro PA, Mancardi GL, Kozak T, Farge-Bancel D, Madan J, Rafia R, Akehurst R, Snowden J.
Bone Marrow Transplant. 2010 Jun;45(6):1014-21. doi: 10.1038/bmt.2009.305.
   
 
ο Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression..
Korganow AS, Knapp AM, Nehme-Schuster H, Soulas-Sprauel P, Poindron V, Pasquali JL, Martin T.
J Autoimmun. 2010 Jun;34(4):426-34. doi: 10.1016/j.jaut.2009.11.002.
   
 
ο New onset of myasthenia gravis after treatment of systemic sclerosis by autologous hematopoietic stem cell transplantation: sustained autoimmunity or inadequate reset of tolerance?.
Deligny C, Clave E, Sibon D, Daikeler T, Keshmandt H, Carmagnat M, Douay C, Arfi S, Clair B, Toubert A, Farge D.
Hum Immunol. 2010 Apr;71(4):363-5. doi: 10.1016/j.humimm.2010.01.013.
   
 
ο Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases..
Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, Ouyang J, Kozak T, Moore J, Kötter I, Chesnel V, Marmont A, Gratwohl A, Saccardi R.
Haematologica, 2010 Feb;95(2):284-92. doi: 10.3324/haematol.2009.013458.
   
 
ο Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis..
Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, Riemekasten G, Cozzi F, Beretta L, Derk CT, Komócsi A, Farge D, Balbir A, Riccieri V, Distler O, Chialà A, Del Papa N, Simic KP, Ghio M, Stamenkovic B, Rednic S, Host N, Pellerito R, Zegers E, Kahan A, Walker UA, Matucci-Cerinic M; EUSTAR co-authors.
Ann Rheum Dis. 2010 Jan;69(1):218-21. doi: 10.1136/ard.2008.103382.
   
  2009
   
 
ο Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring..
Launay D, Marjanovic Z, de Bazelaire C, Florea L, Zohar S, Keshtmand H, Deligny C, de Raigniac A, Wells AU, Farge D.
J Rheumatol. 2009 Jul;36(7):1460-3. doi: 10.3899/jrheum.081212.
   
 
ο Allogeneic hematopoietic SCT for patients with autoimmune diseases.
Daikeler T, Hügle T, Farge D, Andolina M, Gualandi F, Baldomero H, Bocelli-Tyndall C, Brune M, Dalle JH, Urban C, Ehninger G, Gibson B, Linder B, Lioure B, Marmont A, Matthes-Martin S, Nachbaur D, Schuetz P, Tyndall A, van Laar JM, Veys P, Saccardi R, Gratwohl A; Working Party Autoimmune Diseases of the EBMT.
Bone Marrow Transplant. 2009 Jul;44(1):27-33. doi: 10.1038/bmt.2008.424.
   
 
ο Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database..
Walker UA, Tyndall A, Czirják L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Matucci-Cerinic M; EUSTAR co-authors.
Ann Rheum Dis. 2009 Jun;68(6):856-62. doi: 10.1136/ard.2008.091348.
   
 
ο European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research..
Avouac J, Kowal-Bielecka O, Landewe R, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Coauthors.
Ann Rheum Dis. 2009 May;68(5):629-34. doi: 10.1136/ard.2008.095299.
   
 
ο EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)..
Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Co-Authors.
Ann Rheum Dis. 2009 May;68(5):620-8. doi: 10.1136/ard.2008.096677.
   
 
ο Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes..
Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J.
Diabetes Metab. 2009 Apr;35(2):85-93. doi: 10.1016/j.diabet.2008.10.003.
   
 
ο Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study..
Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J, Launay D, Mouthon L, Jego P, Cabane J, de Groote P, Chabrol A, Lazareth I, Guillevin L, Clerson P, Humbert M; ItinérAIR-Sclérodermie Study Investigators.
Rheumatology (Oxford). 2009 Mar;48(3):304-8. doi: 10.1093/rheumatology/ken488.
   
 
ο Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?.
Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D.
Rev Med Interne. 2009 Mar;30(3):287-99. doi: 10.1016/j.revmed.2008.08.019.
   
  2008
   
 
ο Autologous stem cell transplantation for systemic sclerosis..
Farge D, Nash R, Laar JM.
Autoimmunity. 2008 Dec;41(8):616-24. doi: 10.1080/08916930802197305.
   
 
ο Stem cell transplantation: a treatment option for severe systemic sclerosis?.
van Laar JM, Farge D, Tyndall A.
Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii35-8. doi: 10.1136/ard.2008.098384.
   
 
ο Pregnancy and childbirth after treatment with autologous hematopoietic stem cell transplantation for severe systemic sclerosis requiring parenteral nutrition. Ethical issues..
Tyndall AJ, Joly F, Carbonne B, Deligny CN, Farge DC.
Clin Exp Rheumatol. 2008 Nov-Dec;26(6):1122-4.
   
 
ο The antiphospholipid syndrome..
Pasquali JL, Poindron V, Korganow AS, Martin T.
Best Pract Res Clin Rheumatol. 2008 Oct;22(5):831-45. doi: 10.1016/j.berh.2008.08.008.
   
 
ο Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis..
Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Foïs E, Verrecchia F, Daikeler T, Gluckman E, Tyndall A, Bocelli-Tyndall C.
Ann Rheum Dis. 2008 Apr;67(4):443-9.
   
 
ο Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis.
Créange A, Farge-Bancel D.
Rev Neurol (Paris). 2008 Mar;164(3):207-15. doi: 10.1016/j.neurol.2007.10.001.
   
 
ο Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis..
Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, Larghero J, Gluckman E, Preijers FW, van Dijk AP, Bax JJ, Roblot P, van Riel PL, van Laar JM, Farge D.
Ann Rheum Dis. 2008 Jan;67(1):98-104.
   
  2007
   
 
ο Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature..
Daikeler T, Kötter I, Bocelli Tyndall C, Apperley J, Attarbaschi A, Guardiola P, Gratwohl A, Jantunen E, Marmont A, Porretto F, Musso M, Maurer B, Rinaldi N, Saccardi R, Tyndall A; EBMT Autoimmune Diseases Working Party.
Ann Rheum Dis. 2007 Feb;66(2):202-7.
   
 
ο Skin involvement in scleroderma--where histological and clinical scores meet..
Verrecchia F, Laboureau J, Verola O, Roos N, Porcher R, Bruneval P, Ertault M, Tiev K, Michel L, Mauviel A, Farge D.
Rheumatology (Oxford). 2007 May;46(5):833-41.
   
 
ο Pathogenesis of the antiphospholipid syndrome..
Pasquali JL, Poindron V, Korganow AS, Martin T.
Presse Med. 2007 Apr;36(4 Pt 2):667-73.
   
  2005
   
 
ο Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis..
van Laar JM, Farge D, Tyndall A.
Ann Rheum Dis. 2005 Oct;64(10):1515.
   
 
ο Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases..
Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X; Club Rheumatismes et Inflammation (CRI).
Ann Rheum Dis. 2005 Jun;64(6):913-20.
   
 
ο Autologous hematopoietic stem cell transplantation for autoimmune diseases..
Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kötter I, Kozak T, Lisukov I, Löwenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A; Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2005 May;35(9):869-79.
   
 
ο Progress in hematopoietic stem cell transplantation for autoimmune diseases..
Tyndall A, Farge D.
Expert Rev Clin Immunol. 2005 May; 1(1):159-67. doi: 10.1586/1744666X.1.1.159.
   
 
ο Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis..
Farge D, Henegar C, Carmagnat M, Daneshpouy M, Marjanovic Z, Rabian C, Ilie D, Douay C, Mounier N, Clave E, Bengoufa D, Cabane J, Marolleau JP, Gluckman E, Charron D, Toubert A.
Arthritis Rheum. 2005 May;52(5):1555-63.
   
 
ο Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)..
Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, Marjanovic Z, Heneggar C, Papo T, Crickx B, Sereni D, Cabane J, Farge D.
Clin Rheumatol. 2005 Feb;24(1):3-10.
   
  2004
   
 
ο Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis..
Saccardi R, Tyndall A, Coghlan P, Denton C, Edan G, Emdin M, Farge D et al.
Bone Marrow Transplant. 2004 Nov;34(10):877-81.
   
 
ο Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry..
Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, Peter HH, Breedveld FC, Fibbe WE, Black C, Denton C, Koetter I, Locatelli F, Martini A, Schattenberg AV, van den Hoogen F, van de Putte L, Lanza F, Arnold R, Bacon PA, Bingham S, Ciceri F, Didier B, Diez-Martin JL, Emery P, Feremans W, Hertenstein B, Hiepe F, Luosujärvi R, Leon Lara A, Marmont A, Martinez AM, Pascual Cascon H, Bocelli-Tyndall C, Gluckman E, Gratwohl A, Tyndall A; EBMT/EULAR Registry.
Ann Rheum Dis. 2004 Aug;63(8):974-81.
   
 
ο Antiphospholipid antibodies: recent progresses on their origin and pathogenicity..
Pasquali JL, Nehme H, Korganow AS, Martin T.
Joint Bone Spine. 2004 May;71(3):172-4.
   
 
ο Autologous stem cell transplantation for systemic lupus erythematosus..
Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, Hiepe F, Lisukov I, Musso M, Ou-Yang J, Marsh J, Wulffraat N, Besalduch J, Bingham SJ, Emery P, Brune M, Fassas A, Faulkner L, Ferster A, Fiehn C, Fouillard L, Geromin A, Greinix H, Rabusin M, Saccardi R, Schneider P, Zintl F, Gratwohl A, Tyndall A; European Group for Blood and Marrow Transplantation; European League Against Rheumatism Registry.
Lupus. 2004;13(3):168-76.
   
  2003
   
 
ο Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals..
Lieby P, Soley A, Knapp AM, Cerutti M, Freyssinet JM, Pasquali JL, Martin T.
Blood. 2003 Oct 1;102(7):2459-65. Epub 2003 Jun 5.
   
  2002
   
 
ο Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study..
Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N, Hachulla E, Philippe P, Sibilia J, Rabian C, Chevret S, Gluckman E; Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group.
Br J Haematol. 2002 Dec;119(3):726-39.
   
  2001
   
 
ο Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease..
Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, Espigado I, Hertenstein B, Hiepe F, Kashyap A, Kötter I, Marmont A, Martinez A, Pascual MJ, Gratwohl A, Prentice HG, Black C, Tyndall A.
Ann Rheum Dis, 2001 Jun;60(6):577-84.
   
  2000
   
 
ο Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells
Martin T, Weber JC, Levallois H, Labouret N, Soley A, Koenig S, Korganow AS, Pasquali JL.
Arthritis Rheum. 2000 Apr;43(4):908-16.
   
  1999
   
 
ο From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.
Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D.
Immunity. 1999 Apr;10(4):451-61.
   
  1994
   
 
ο Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain.
Martin T, Crouzier R, Weber JC, Kipps TJ, Pasquali JL.
J Immunol. 1994 Jun 15;152(12):5988-96.
   
 
ο Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor V beta regions depending on the stage of the disease.
Legras F, Martin T, Knapp AM, Pasquali JL.
Eur J Immunol. 1994 Jan;24(1):181-5.
   
  1993
   
 
ο Lacrimal and salivary lymphoma in primary Sjögren's syndrome.
Weber JC, Martin T, Blaison G, Labouret N, Sahel J, Storck D, Pasquali JL.
Ann Med Interne (Paris). 1993;144(8):567.
   
  1992
   
 
ο Evidence for somatic selection of natural autoantibodies.
Martin T, Duffy SF, Carson DA, Kipps TJ.
J Exp Med. 1992 Apr 1;175(4):983-91
.
   
     
  Maladies Auto Immunes et Thérapie Cellulaire maj : 07/09/2017